GE
ETFMG Treatments, Testing and Advancements ETF (GERM)
·Financial Services·Asset Management
$19.16
—
Mkt Cap $9.59M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$227.70
Range $154.44 – $267.30
Implied Upside
+1088.6%
Consensus $227.70 vs current $19.16